L-tryptophan administration promotes the reversion of pre-established chronic liver injury in rats treated with carbon tetrachloride

Abstract

We examined the effect of L-tryptophan (Trp) administration on the reversion of CCl 4-induced chronic liver injury after hepatotoxicant withdrawal in rats. When rats treated with CCl 4 twice a week for 6 weeks were released from CCl 4 treatment for 2 weeks, there was an incomplete reversion of liver injury. The reversion was enhanced by 2 weeks of daily intraperitoneal administration of Trp (50 mg/kg body weight), starting just after CCl 4 withdrawal. There were increases in the levels of thiobarbituric acid reactive substances, an index of lipid peroxidation, Ca 2+, triglycerides, and Trp, and decreases in tryptophan 2,3-dioxygenase activity and serum triglyceride concentrations in the liver of rats treated with CCl 4 for 6 weeks. Serum albumin concentrations and in vitro hepatic protein synthesis activity did not change in the CCl 4-treated rats. The changes in the CCl 4-treated rats were partially attenuated 2 weeks after CCl 4 withdrawal. The attenuation was enhanced by 2 weeks of daily Trp administration. The increases in hepatic thiobarbituric acid reactive substances and triglycerides and the decreases in hepatic tryptophan 2,3-dioxygenase activity and serum triglyceride concentrations observed 2 weeks after CCl 4 withdrawal were almost completely attenuated by Trp administration. In vitro hepatic protein synthesis in CCl 4-treated and untreated rats was increased by 2 weeks of daily Trp administration. These results indicate that Trp administration promotes the reversion of pre-established chronic liver injury in rats treated with CCl 4, and suggest that Trp exerts this effect by enhancing the improvement of several parameters of liver dysfunction associated with chronic liver injury and by stimulating hepatic protein synthesis.